Inhaled sedation was recently approved in Europe as an alternative to intravenous sedative
drugs for intensive care unit (ICU) sedation. The aim of this narrative review was to …

The discovery and utilization of volatile anesthetics has significantly transformed surgical
practices since their inception in the mid-19th century. Recently, a paradigm shift is …

Background Current intensive care unit (ICU) sedation guidelines recommend strategies
using non-benzodiazepine sedatives. This survey was undertaken to explore inhaled ICU …

Background The COVID-19 pandemic has increased the number of patients in ICUs leading
to a worldwide shortage of the intravenous sedative agents obligating physicians to find …

Introducción y objetivos En las unidades de cuidados intensivos (UCI) la sedación se utiliza
para mejorar el bienestar y la tolerancia durante la ventilación mecánica, en las …

Background Optimal intensive care of patients undergoing valve surgery is a complex
balancing act between sedation for monitoring and timely postoperative awakening. It …

Abstract Background The MIRUS™(TIM, Koblenz, Germany) is an electronical gas delivery
system, which offers an automated MAC (minimal alveolar concentration)-driven application …

The MIRUS™ system enables automated end-expired control of volatile anaesthetics. The
device is positioned between the Y-piece of the breathing system and the patient's airway …

Abstract AnaConDa-100 ml (ACD-100, Sedana Medical, Uppsala, Sweden) is well
established for inhalation sedation in the intensive care unit. But because of its large dead …

Background MIRUS™ is a device for target‐controlled inhalational sedation in the ICU in
combination with use of isoflurane, or sevoflurane, or desflurane. The feasibility of this …